In the current report, we aimed to examine TARBP2 for its role in HCC progression and to explore related regulatory pathways, taking advantage of clinical specimens and well-characterized liver cancer/normal liver cell lines. The gene discussed is TARBP2; the disease is hepatocellular carcinoma.